G
Gwo-Bin Lee
Researcher at National Tsing Hua University
Publications - 560
Citations - 16471
Gwo-Bin Lee is an academic researcher from National Tsing Hua University. The author has contributed to research in topics: Aptamer & Dielectrophoresis. The author has an hindex of 64, co-authored 549 publications receiving 14563 citations. Previous affiliations of Gwo-Bin Lee include National Cheng Kung University & National Chiao Tung University.
Papers
More filters
Journal ArticleDOI
Isolation and recovery of extracellular vesicles using optically-induced dielectrophoresis on an integrated microfluidic platform.
TL;DR: In this article, a pneumatically-driven microfluidic platform was used for label-free, contact-free isolation and recovery of extracellular vesicles via optically-induced dielectrophoresis.
Journal ArticleDOI
An integrated microfluidic platform featuring real-time reverse transcription loop-mediated isothermal amplification for detection of COVID-19
TL;DR: An integrated microfluidic platform (IMP) utilizing real-time reverse-transcription loop-mediated isothermal amplification (RT-LAMP) was developed in this article for detection and quantification of three genes of SARS-CoV-2.
Journal ArticleDOI
Microchip and capillary electrophoresis for quantitative analysis of hepatitis C virus based on RT-competitive PCR.
TL;DR: The method was further demonstrated for the quantitation of clinical patients with low, medium, and high viral titer and the results were found to be comparable to those determined by the commercial bDNA assay.
A Micromachined Low-power-consumption Portable PCR System
TL;DR: In this paper, the authors presented a portable system for polymerase chain reaction (PCR) which is comprised of two basic components, namely a PCR control module and a PCR chip module, which is fabricated from cheap and biocompatible soda-lime glass and PDMS materials.
Journal ArticleDOI
A miniaturized, DNA-FET biosensor-based microfluidic system for quantification of two breast cancer biomarkers
TL;DR: An integrated microfluidic system (IMS) was developed herein for quantifying concentrations of breast cancer biomarkers including microRNA-195 and micro RNA-126, highlighting its potential as a sensitive platform for early-stage breast cancer diagnosis.